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Abstract. Based on the Indonesian Renal Registry (IRR) data in 2015, the highest incidence 
of comorbidities in hemodialysis patients in Indonesia was hypertension (50%). Obstructive 
Sleep Apnea (OSA) is one of the causes of secondary hypertension, the characteristics of 
hypertension in OSA are more resistant to treatment. One of the causes of resistant 
hypertension is patient non-compliance with the consumption of antihypertensive drugs. 
Keyword: Adherence to antihypertensive consumption, hemodialysis, obstructive sleep 
apnea. 
Abstrak. Berdasarkan data Indonesian Renal Registry (IRR) pada tahun 2015, insiden 
komorbiditas tertinggi pada pasien hemodialisis di Indonesia adalah hipertensi (50%). 
Obstructive Sleep Apnea (OSA) adalah salah satu penyebab hipertensi sekunder, 
karakteristik hipertensi pada OSA lebih resisten terhadap pengobatan. Salah satu penyebab 
hipertensi resisten adalah ketidakpatuhan pasien dengan konsumsi obat antihipertensi. 
Kata Kunci: Kepatuhan Terhadap Konsumsi Antihipertensi, Hemodialisis, Apnea Tidur 
Obstruktif. 
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1. Introduction 
Australian and New Zealand Dialysis and Transplant(ANZDATA) states that among 15.4 deaths 
per 100 dialysis patients / year, 40% are caused by cardiovascular disease. One of the causes of 
death due to cardiovascular disease is hypertension.1 Based on IRR data in 2015, the biggest 
cause of chronic renal disease (CKD) with dialysis was hypertension by 44%.2 
Obstructive sleep apnea is one of the causes of secondary hypertension. Approximately 50% of 
subjects with OSA are estimated to suffer from hypertension, while 30-40% of subjects with 
hypertension are estimated to suffer from OSA. The characteristics of hypertension in OSA are 
more resistant to treatment. Patients who meet the criteria for resistant hypertension may have 
non-compliance with antihypertensive treatment in 53% of cases.3,4 
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Therefore, the authors are interested in conducting a study of the relationship between obstructive 
sleep apnea with adherence to the consumption of antihypertensive drugs in hemodialysis 
patients. 
2. Methodology 
This study was an analytical observational study with a cross-sectional design study. This cross 
sectional study was performed at Rasyida Kidney Hospital and was to be started after ethical 
clearance (No. 53 / TGL / KEPK FK USU-RSUP HAM / 2018) was issued by the Ethics 
Commission FK USU on 89 regular hemodialysis patients. 
The questionnaire consisted of three parts,the first part of the questionnaire containing data on 
respondents' characteristics including age, gender, body mass index, smoking history and duration 
of hemodialysis. The second part of the questionnaire is STOP-BANG questionnaire, to measure 
the degree of risk of OSA in patients. The third part of the questionnaire is MMAS (Morisky 
Medication Adherence Scale) to measure the level of patient compliance with antihypertensive 
treatment. 
 
3.  Result 
In this study showed that regular HD patients who consumed the most antihypertensive 
drugs were older adults (40-60 years) as many as (55.1%) with an average age (49.31 ± 
12.754) years and the most sex was male. as many as (69.7%). The length of HD that 
the patient lived on average (34.96 ± 36.120) months. Body mass index (BMI) of most 
patients is normal (18.5-25 kg / m²) as much as (57.3%). Based on the history of 
smoking more HD patients who do not smoke (95.5%). 
The prevalence of HD patients who experience OSA is (39.3%) with the degree of risk 
of Obstructive Sleep Apnea (OSA) based on STOP-BANG is low, moderate, high 
respectively(9%),(51.7%),and(39,3%). 
The prevalence of HD patients who adhere to more hypertension drug consumption 
(57.3%) with the degree of compliance with drug consumption based on the Morisky 
Scale is low, medium, high respectively (42.7%), (30.3%), and (27 %). 
 
4. Discussion 
The study sample was 89 regular hemodialysis patients who underwent antihypertensive 
treatment at the Rasyida Kidney Hospital. In this study it was found that the highest 
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proportion who underwent HD were older adults (40-60 years) as much as (55.1%) in line 
with IRR data where the highest proportion was 45-64 years (61.6%).6 
The sex that was most obtained was men (69.7%). In line with the study of Ogna et al 
(63.5%) and Muzasti et al (63.4%) studies.5,7 
The length of HD that patients undergo averaged (34.96 ± 36,120) months a little shorter 
than the results of a study by Muzasti et al at (41.4 ± 24.4) months.7 
The highest proportion of BMI of patients is normal (18.5-25 kg / m²) at 57.3% with an 
average of 24.08 ± 4.359 in line with the study of Ogna et al (26.6 ± 4.4) and Righi et al 
(29.9 ± 5.3).5,4 
Based on the history of comorbidities of HD patients who took antihypertensive drugs, 
can be associated with a fairly good lifestyle in terms of the smoking history of the 
patients who mostly did not smoke as much (95.5%). 
 
The prevalence of HD patients with OSA (39.3%) with a risk degree of Obstructive Sleep 
Apnea (OSA) based on STOP-BANG are low, moderate and high (9%, 51.7%, and 39.3% 
, respectively). In the study of Ogna et al, HD patients who had a high risk of OSA were 
(64.4%) with a score of ≥3 considered as a high risk of OSA.5 
The prevalence of HD patients who adhere to the consumption of hypertension drugs is 
(57.3%) with the degree of drug consumption compliance based on the Morisky Scale are 
low, medium, high each at (42.7%), (30.3%), and (27 %). In this study, HD patients who 
took antihypertensive drugs tend to not adhere to treatment because patients intentionally 
stopped treatment. In line with the research of Murali et al., As many as (74%) HD 
patients discontinued treatment because of 'other reasons' that included patients who did 
not want to continue treatment.8 
In this study there was no significant relationship between adherence to drug consumption 
with OSA risk (p = 0.679) but was significantly affected by age (p = 0.0001), body mass 
index (p = 0.001), and gender (p = 0.03). In this study the mean age (54,857 ± 11,206) 
was younger than that of the Ogna et al (65.2 ± 14.1). In the study of Bixler et al., The 
effect of age on the prevalence of sleep apnea is still unclear, in the study, the prevalence 
of sleep apnea tends to increase with age, but the clinical significance (severity) of apnea 
decreases.5,9 
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In this study the highest proportion of sex was male, in line with the study of Ogna et al 
which obtained the highest proportion of men (p = 0.03). According to Soeroso N., the 
prevalence of OSA in men was more than women due to endocrine factors, but OSA can 
also occur in women who experience disorders that will increase androgen and 
consumption of androgen drugs.5,10 
In this study the average BMI of patients was (25.833 ± 4.639) In line with the study of 
Sivalingam et al (p = 0.007) with the mean BMI (22.4 ± 3.7). According to Soeroso N., 
one of the causes of OSA is obesity, especially in the upper part of the body, where fat is 
accumulated in the neck area which will cause compression of the pharynx.10,11 
In this study there was no significant relationship between the duration of hemodialysis 
and OSA risk level (p = 0.242) with the average duration of hemodialysis (39.485 ± 
44.014), HD patients with hemodialysis> 25 months long tended to be more at risk (20 
vs 15%). However, the Ogna et al. Study found a significant correlation between the 
duration of hemodialysis and OSA risk levels (p = 0.026).5 
In this study there was no significant association between smoking history and OSA risk 
level (p = 0.548). In line with the study of Masuda et al (p = 0.101) and Losso et al 
(p=0.78).12,13 
 
Table 1 Characteristics of Regular HD patients at Rasyida Kidney Hospital Medan 
Variabel Mean ± SD, n (%) 
Age (year) 49.31 ± 12.754 
      Young adults (18-40) 22 (24.7) 
      Old adults (40-60) 49(55.1) 
      Elderly (>60) 18(20.2) 
Gender  
      Male 62(69.7) 
      Female 27(30.3) 
Duration of hemodialysis 34.96  ± 36.120 
      ≤25 months 45(50.6) 
      >25 months 44(49.4) 
Body Mass Index (BMI) 24.08 ± 4.359 
      Thin (<18,5 kg/m²) 6(6.7) 
      Normal (18,5-25 kg/m²) 51(57.3) 
      Fat (25-30 kg/m²) 21(23.6) 
      Obesity (>30 kg/m²) 11(12.4) 
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Smoking History  
      Yes 4(4.5) 
      No 85(95.5) 
OSA Risk Degree(STOP-BANG Score)  
      Low risk (0-2) 8(9.0) 
      Medium risk (3-4) 46(51.7) 
      High risk (5-8) 35(39.3) 
OSA Risk Degree  
      High risk OSA 35(39.3) 
      Medium – low risk OSA 54(60.7) 
Adherence to drug consumption (MMAS Score)  
      Low adherence (<6) 38(42.7) 
      Medium adherence (6-7) 27(30.3) 
      High adherence (8) 24(27.0) 
Adherence to drug consumption  
      High – medium adherence 51(57.3) 
      Low adherence 38(42.7) 
 
 
Table 2 characteristics data of HD patients with OSA risk levels 
 Total n=89 High Risk 
OSA 
Mean ± SD, 
n (%) 
Medium to 
Low Risk OSA 
Mean ± SD, n 
(%) 
p OR(95%CI) 
Adherence to drug 
consumption 
 5.676 ± 
2.211 
5.454 ± 2.062 0.679 1.200 
      High to medium 
adherence (6-8) 
51 21(41.2) 30(58.8)  0506 ± 2.845 
      Low adherence 
(<6) 
38 14(36.8) 24(63.2)   
Age  54.857 ± 
11.206 
45.722 ± 12.493 0.0001a 5.000 
      Adult (≤50) 46 10(21.7) 36(78.3)  1.988 ± 12.625 
      Old (>50) 43 25(58.1) 18(41.9)   
Gender    0.002a 0,174 
      Male 62 31(50) 31(50)  0.54 ± 0.562 
      Female 27 4(14.8) 23(85.2)   
Duration of 
hemodialysis 
 39.485 ± 
44.014 
32.018 ± 30.018 0.242 1.667 
      New (≤25 45 15(33.3) 30(66.7)  0.707 ± 3.931 
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bulan) 
      Old (>25bulan) 44 20(45.5) 24(54.5)   
Body Mass Index 
(BMI) 
 25.833 ± 
4.639 
22.957 ± 3.797 0.001a 4.667 
      Normal 
(≤25kg/m2) 
57 15(26.3) 42(73.7)  1.846 ± 11.795 
      Obesity (>25 
kg/m2) 
32 20(62.5) 12(37.5)   
Smoking History    0.548 2.000 
      Yes 4 1(25.0) 3(75.0)  0.200 ± 20.036 
      No 85 34(40.0) 51(60.0)   
aSignificant (p-value< 0.05)  
 
In this study the average BMI of patients was (25,833 ± 4,639) In line with the study of Sivalingam 
et al (p = 0.007) with the mean BMI (22.4 ± 3.7). According to Soeroso N., one of the causes of 
OSA is obesity, especially in the upper part of the body, where fat is accumulated in the neck area 
which will cause compression of the pharynx.13,11 
In this study there was no significant relationship between the duration of hemodialysis and OSA 
risk level (p = 0.242) with the average duration of hemodialysis (39.485 ± 44.014), HD patients 
with hemodialysis > 25 months long tended to be more at risk (20 vs 15%). However, the Ogna 
et al. Study found a significant correlation between the duration of hemodialysis and OSA risk 
levels (p = 0.026).6 
In this study there was no significant association between smoking history and OSA risk level (p 
= 0.548). In line with the study of Masuda et al (p = 0.101) and Losso et al (p=0.78).12,13 
In this study, based on multivariate analysis there was no correlation between the level of 
adherence to the consumption of antihypertensive drugs and OSA risk levels in regular HD 
patients, due to the lack of consistency of HD patients in undergoing treatment.8 
However, in this study it was found that OSA was significantly affected by age as the dominant 
risk factor where the risk of regular HD patients with old age (> 50 years) and BMI (> 25 kg/m2) 
were 6.449 times and 6.130 times the chances of experiencing OSA compared to patients with 
young age (≤ 50 years ) and lower BMI (≥ 25 kg/m2), In line with the study of Ogna et al, who 
obtained an age factor of > 70 years affected obstructive sleep apnea (OR 1.12; p = 0.07).6 
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Table 3 The final model of multiple logistic regression tests 
Variabel OR p value 95% CI 
Age 6.449 0.001 2.246 – 18.520 
Body Mass Index 6.130 0.001 2.105 – 17.849 
 
In theory, in line with Eckert et al, that anatomic susceptibility to OSA appears to deteriorate and 
there is increased fat around the neck as we age. In addition there can also be a loss of lung 
elasticity as we age, which can affect the upper airway mechanism.14 
 
4. Conclusion 
1. The prevalence of obstructive sleep apnea in HD patients is (39.3%) with the highest degree 
of OSA risk is moderate risk (51.7%). 
2. There was no significant relationship between adherence to drug consumption with OSA risk 
(p = 0.679) but was significantly affected by age (p = 0.0001), body mass index (p = 0.001), 
and gender (p = 0.03). 
3. Based on multivariate analysis, it was found that OSA was influenced by age and BMI as the 
dominant factor in which the risk of patients aged (> 50 years) and BMI (> 25 kg / m2) was 
6.449 and 6.130 times OSA compared to adult patients (≤ 50 years) and BMI (≤25 kg / m2). 
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